摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(-)-1,2,14,15-tetradehydroaspidospermidine | 32975-46-5

中文名称
——
中文别名
——
英文名称
(-)-1,2,14,15-tetradehydroaspidospermidine
英文别名
(1R,12R,19S)-12-ethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,8,13-pentaene
(-)-1,2,14,15-tetradehydroaspidospermidine化学式
CAS
32975-46-5
化学式
C19H22N2
mdl
——
分子量
278.397
InChiKey
VDWYRKQTLMTCHB-FHWLQOOXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    15.6
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090

SDS

SDS:d93d5071a2abef140d12d4c2d35e0b89
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (-)-1,2,14,15-tetradehydroaspidospermidineplatinum(IV) oxide氢气 作用下, 以 乙醇 为溶剂, 反应 16.0h, 以75%的产率得到(-)-14,15-didehydroaspidospermidine
    参考文献:
    名称:
    Domino Michael/Mannich/N-烷基化途径到 Aspidosperma 生物碱的四氢咔唑框架:(-)-Aspidospermidine、(-)-Tabersonine 和 (-)-Vincadifformine 的简明全合成
    摘要:
    我们报告了一种新的、不对称的多米诺骨牌迈克尔/曼尼希/N-烷基化序列,用于快速组装 Aspidosperma 生物碱的四氢咔唑框架。该方法用于经典目标 (-)-aspidospermidine、(-)-tabersonine 和 (-)-vincadifformine 的 10 或 11 步简明全合成。其他关键步骤包括闭环复分解制备 D 环和 Bosch-Rubiralta 螺环化制备 C 环。
    DOI:
    10.1021/ja408114u
  • 作为产物:
    参考文献:
    名称:
    芳烃融合的米歇尔·迈克尔/曼尼希反应的发展和范围:在孢霉属生物碱(-)-曲霉精,(-)-他布森碱和(-)-长春花碱的总合成中的应用
    摘要:
    描述了芳烃融合的多米诺骨牌迈克尔/曼尼希路线的开发和应用,将其与曲霉生物碱的四氢咔唑(ABE)核心结合使用。就亲核组分(即,N-亚磺酰基金属亚胺)和亲电组分(即,迈克尔受体)研究了该新型转化的范围。还讨论了该方法在10-11个步骤中分别分别成功合成简明的吲哚生物碱(-)-aspidospermidine,(-)-tabersonine和(-)-vincadifformine的简明总合成方法。
    DOI:
    10.1021/acs.joc.6b02551
点击查看最新优质反应信息

文献信息

  • An Efficient Approach to <i>Aspidosperma </i>Alkaloids via [4 + 2] Cycloadditions of Aminosiloxydienes:  Stereocontrolled Total Synthesis of (±)-Tabersonine. Gram-Scale Catalytic Asymmetric Syntheses of (+)-Tabersonine and (+)-16-Methoxytabersonine. Asymmetric Syntheses of (+)-Aspidospermidine and (−)-Quebrachamine
    作者:Sergey A. Kozmin、Tetsuo Iwama、Yong Huang、Viresh H. Rawal
    DOI:10.1021/ja017863s
    日期:2002.5.1
    readily adapted to the asymmetric synthesis of these compounds. The strategy is demonstrated by the total synthesis of (+/-)-tabersonine (rac-1), proceeding through a 12-step sequence. The basis for this approach was provided by a highly regio- and stereoselective [4 + 2] cycloaddition of 2-ethylacrolein with 1-amino-3-siloxydiene developed in our laboratory. Subsequent elaboration of the initial adduct
    描述了一种简洁、高度立体控制的吲哚生物碱 Aspidosperma 家族的策略,该策略很容易适应这些化合物的不对称合成。该策略由 (+/-)-tabersonine (rac-1) 的全合成证明,通过 12 步序列进行。这种方法的基础是我们实验室开发的 2-乙基丙烯醛与 1-氨基-3-甲硅烷氧基二烯的高度区域和立体选择性 [4 + 2] 环加成。随后通过闭环烯烃复分解反应有效地将初始加合物加工成六氢喹啉 DE 环系统。开发了烯醇甲硅烷基醚与(邻硝基苯基)苯基碘氟化物的新型邻硝基苯基化,以实现必要的吲哚部分的有效区域选择性引入。ABDE四环最终高产转化为五环目标rac-1依赖于分子内吲哚烷基化和区域选择性C-碳甲氧基化。我们的方法在战略上与以前的路线不同,并且包含访问 Aspidosperma 吲哚生物碱家族的许多其他成员所必需的内置灵活性。通过以下 Aspidosperma 生物碱的不对称
  • A biomimetic entry in the hexacyclic tuboxenin ring system methylene-indolines, indolenines and indoleniniums, XXII
    作者:Georgette Hugel、Janine Cossy、Jean Levy
    DOI:10.1016/s0040-4039(00)95417-0
    日期:1987.1
    indolenine was reacted with Na in THF to yield tuboxenine , 19-épi tuboxenine , indoline and the two indoles and .
    吲哚列宁与Na在THF中反应产生了图博宁,19-épi图博宁,吲哚啉和两个吲哚和吲哚。
  • A General Strategy to <i>Aspidosperma</i> Alkaloids:  Efficient, Stereocontrolled Synthesis of Tabersonine
    作者:Sergey A. Kozmin、Viresh H. Rawal
    DOI:10.1021/ja983198k
    日期:1998.12.1
  • D-ring substituted rhazinilam analogues: semisynthesis and evaluation of antitubulin activity
    作者:Christophe Dupont、Daniel Guénard、Luba Tchertanov、Sylviane Thoret、Françoise Guéritte
    DOI:10.1016/s0968-0896(99)00241-2
    日期:1999.12
    Novel (-)- and (+)-rhazinilam derivatives substituted on the D-ring (compounds 3, 4, 5 and 6) have been prepared from (+)-vincadifformine 7 and (-)-tabersonine and evaluated against the disassembly of microtubules into tubulin. Along with this study, a reproducible 'one pot' semisynthesis of (-)-rhazinilam 1 from (+)-1,2-didehydroaspidospermidine 2 was performed allowing the easy preparation of these new compounds. (C) 1999 Elsevier Science Ltd. All rights reserved.
  • New dimeric indole alkaloids from Stenosolen heterophyllus: structure determinations and synthetic approach
    作者:Amelia Henriques、Christiane Kan、Angele Chiaroni、Claude Riche、Henri Philippe Husson、Siew Kwong Kan、Mauri Lounasmaa
    DOI:10.1021/jo00344a011
    日期:1982.2
查看更多

同类化合物

长春立辛 长春新碱M1 脱乙酰基文多灵 罗西定碱 温都罗新 文多灵 它波宁盐酸盐 它勃宁 Ervamycine; 11-甲氧基水甘草碱 4',5'-二去氢-4'-脱氧-2',19'-二氧代-2',19'-仲长春碱 11-羟基他波宁 (-)-14,15-didehydroaspidospermidine 4-deacetyl-4-propoxylvindoline hydroxyvinamidine 4-deacetyl-4-butoxylvindoline 4-deacetyl-4-(cyclohexanecarbonyl)oxyvindoline vinamidine jerantinine A acetate N-[[(1R,9R,12R,14S,19R)-14-ethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6-trien-11-ylidene]amino]-4-methylbenzenesulfonamide 16-methoxy-1-methyl-6,7-didehydro-aspidospermidin-4-one (+)-20R-1,2-dehydro-Ψ-aspidospermidine methyl (1R,9R,10S,12S,19S)-12-ethenyl-8,16-diazahexacyclo[10.6.1.01,9.02,7.08,10.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate (1R,9R,12R,19R)-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6-triene-11,17-dione methyl (1R,9R,10S,12R,19S)-12-ethyl-8,16-diazahexacyclo[10.6.1.01,9.02,7.08,10.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate 3-Oxo-11-methoxytabersonine Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12beta,19alpha)- melodinine P N-methyltabersonine 14,15-didehydro-16-hydroxy-<3H>indole ent-N(1)-methyl-14,15-didehydroaspidospermidine vindoline hydrochloride Mbid (3aS,5R,10bR,12bS)-5-Chloro-3a-ethyl-12-oxo-2,3,3a,4,5,11,12,12b-octahydro-1H-6,12a-diaza-indeno[7,1-cd]fluorene-5-carboxylic acid methyl ester (3aS,5R,10bR,12R,12bS)-5-Chloro-12-cyano-3a-ethyl-2,3,3a,4,5,11,12,12b-octahydro-1H-6,12a-diaza-indeno[7,1-cd]fluorene-5-carboxylic acid methyl ester (3aS,5aR,10bR,12bR)-6-Ethyl-2,3,3a,5a,6,12b-hexahydro-1H,5H-6,12a-diaza-indeno[7,1-cd]fluorene-4,12-dione jerantinine A jerantinine C 10-O-methyljerantinine A baloxine 2βH,3αH-tubersonine methyl 15-bromo-2,3,6,7-tetrahydro-(5α,12β,19α)-aspidospermidine-3-carboxylate methyl 15-bromo-6,7-didehydro-(2β,5α,12β,19α)-aspidospermidine-3α-carboxylate 2,3-didehydro-20,21-dinor-aspidospermidine-3-carboxylic acid methyl ester methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(1R,3S,14R)-18-ethyl-3-methoxycarbonyl-14-[[(2S)-2-methoxycarbonylpyrrolidin-1-yl]methyl]-5,16-diazatetracyclo[14.3.1.04,12.06,11]icosa-4(12),6,8,10,18-pentaen-3-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate 20-deethyl-17-ethoxy-1-(p-tolylsulfonyl)-2,16,17,20-tetradehydroaspidospermidine 3α-acetonyl-tabersonine 20-desethyl-17-formyl-5-oxo-16,17-dehydroaspidospermidine Alkaloid XC-99 16-Chloro-1-dehydrovincadifformine Methyl 11-acetyloxy-12-ethyl-4-[(Z)-1-(16-ethyl-16-hydroxy-3,13-diazatetracyclo[11.2.2.02,10.04,9]heptadeca-2(10),4,6,8-tetraen-15-yl)-3-methoxy-3-oxoprop-1-en-2-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate